Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03009162
What this trial is testing

Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function

Who this might be right for
Migraine
Eli Lilly and Company 16
Testing effectiveness (Phase 2)Study completedNCT02021370
What this trial is testing

15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 121
Large-scale testing (Phase 3)Ended earlyNCT00958269
What this trial is testing

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Phenomix 360
Early research (Phase 1)Study completedNCT01830205
What this trial is testing

Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 58
Large-scale testing (Phase 3)Study completedNCT01704079
What this trial is testing

Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, SecondaryVitamin D Deficiency
OPKO IP Holdings II, Inc. 216
Testing effectiveness (Phase 2)Study completedNCT00436683
What this trial is testing

Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia

Who this might be right for
Chronic Kidney Failure
Ineos Healthcare Limited 64
Early research (Phase 1)Study completedNCT03992066
What this trial is testing

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease

Who this might be right for
Anemia Associated With Chronic Kidney Disease
Akebia Therapeutics 46
Early research (Phase 1)Study completedNCT01424176
What this trial is testing

Dexpramipexole Renal PK Study

Who this might be right for
Amyotrophic Lateral SclerosisRenal Insufficiency
Knopp Biosciences 36
Testing effectiveness (Phase 2)Study completedNCT03799627
What this trial is testing

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

Who this might be right for
AnemiaDialysis-dependent Chronic Kidney Disease
Akebia Therapeutics 175
Testing effectiveness (Phase 2)Study completedNCT01082640
What this trial is testing

Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment

Who this might be right for
Renal Impairment
Takeda 96
Early research (Phase 1)Study completedNCT03836599
What this trial is testing

Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects

Who this might be right for
Chronic Kidney Disease
AstraZeneca 6
Large-scale testing (Phase 3)Study completedNCT00542815
What this trial is testing

MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 632
Early research (Phase 1)Study completedNCT02020434
What this trial is testing

The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency

Who this might be right for
Subjects With Varying Degrees of Renal Insufficiency andSubjects With Normal Renal Function
Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) 32
Testing effectiveness (Phase 2)Study completedNCT00159614
What this trial is testing

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

Who this might be right for
Heart Failure, CongestiveRenal Insufficiency
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 30
Large-scale testing (Phase 3)Ended earlyNCT04968184
What this trial is testing

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Diseases
KBP Biosciences 652
Large-scale testing (Phase 3)Ended earlyNCT00436748
What this trial is testing

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

Who this might be right for
AnemiaChronic Kidney DiseaseKidney Disease
Amgen 116
Early research (Phase 1)Study completedNCT03402438
What this trial is testing

Renal Impairment Study

Who this might be right for
Clinical Trial, Phase I
Bayer 36
Large-scale testing (Phase 3)Study completedNCT02652806
What this trial is testing

FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease

Who this might be right for
Anemia
Kyntra Bio 305
Early research (Phase 1)Study completedNCT05032235
What this trial is testing

Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Renal Impairment
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)UnknownNCT04414852
What this trial is testing

Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function

Who this might be right for
Subjects With Impaired Renal Function and Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd. 24
Next Page